CTLA-4 Blockage Increases Resistance to Infection with the Intracellular Protozoan Trypanosoma cruzi

Journal of Immunology

Volumn 172, Issue 8, 2004, Pages 4893-4901

  Martins, Gislâine Aparecida ^a   Tadokoro, Carlos Eduardo ^a   Silva, Roberta Borges ^a   Silva, João Santana ^a   Rizzo, Luiz Vicente ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO ZERBINI   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; NITRIC OXIDE; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CHAGAS DISEASE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION RESISTANCE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CRUZI;

EID: 1842581712     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.8.4893     Document Type: Article

References (58)

1. Prata, A. 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1-92.
2. DosReis, G. A. 1997. Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol. Today 13:335.
3. Abrahamsohn, I. A., R. L. Coffman. 1995. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155: 3955.
4. Martins, G. A., M. A. Cordoso, J. C. Aliberti, and J. S. Silva. 1998. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol. Lett. 63:113.
5. Vespa, G. N. R., F. Q. Cunha, and J. S. Silva. 1994. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:5177.
6. Martins, G. A., L. Q. Vieira, F. Q. Cunha, and J. S. Silva. 1999. γ Interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect. Immun. 67:3864.
7. Silva, J. S., G. N. R. Vespa, M. A. G. Cardoso, J. C. S. Aliberti, and F. Q. Cunha. 1995. Tumor necrosis factor a mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected γ interferon-activated macrophages. Infect. Immun. 63:4862.
8. McCabe, R. E., S. G. Meagher, and B. T. Mullins. 1991. Endogenous interferon-γ, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi. J. Infect. Dis. 163:912.
9. Muller, U., G. Kohler, H. Mossmann, G. A. Schaub, G. Alber, J. P. Di Santo, F. Brombacher, and C. Holscher. 2001. IL-12-independent IFN-γ production by T cells in experimental Chagas' disease is mediated by IL-18. J. Immunol. 167: 3346.
10. Martins, G. A., S. B. Petkova, F. S. Machado, R. N. Kitsis, L. M. Weiss, M. Wittner, H. B. Tanowitz, and J. S. Silva. 2001. Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. Immunology 102:1.
11. Holscher, C., G. Kohler, U. Muller, H. Mossmann, G. A. Schaub, and F. Brombacher. 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in γ interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66:1208.
12. 2) in Trypanosoma cruzi-infected mice. J. Mol. Cell Cardiol. 31:75.
13. Chambers, C. A., and J. P. Allison. 1999. Costimulatory regulation of T cell function. Curr. Opin. Immunol. 11:203.
14. Brunner, M. C., C. A. Chambers, F. K. Chan, J. Hanke, A. Winoto, and J. P. Allison. 1999. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162:5813.
15. Alegre, M. L., P. J. Noel, B. J. Eisfelder, E. Chuang, M. R. Clark, S. L. Reiner, and C. B. Thompson. 1998. Regulation of surface and intracellular expression of CTLA-4 on mouse T cells. J. Immunol. 157:4762.
16. Oosterwegel M. A., R. J. Greenwald, D. A. Mandelbrot, R. B. Lorsbach, and A. H. Sharpe. 1999. CTLA-4 and T cell activation. Curr. Opin. Immunol. 11:294.
17. Alegre, M. L., K. A. Frauwirth, and C. B. Thompson. 2001. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 3:220.
18. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
19. + T cell responses. Proc. Natl. Acad. Sci. USA 96:8603.
20. Greenwald, R. J., M. A. Oosterwegel, D. van Der Woude, A. Kubal, D. A. Mandelbrot, V. A Boussiotis, and A. H. Sharpe. 2002. CTLA-4 regulates cell cycle progression during a primary immune response. Eur. J. Immunol. 2:366.
21. Greenwald, R. J., V. A. Boussiotis, R. B. Lorsbach, A. K. Abbas AK, and A. H. Sharpe. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity 14:145.
22. Waterhouse, P. J., M. Penninger, E. Timms, A. Wakeham. A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
23. Tivol, E. A. F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 5:541.
24. Leach, D. R., M. F. Krummel, and J. P. Allison. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
25. Egen, J. G., M. S. Kuhns, and J. P. Allison. 2002. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3:611.
26. Hurwitz, A. A., T. J. Sullivan, R. A. Sobel, and J. P. Allison. 2002. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc. Natl. Acad. Sci. USA 99:3013.
27. Chang, T. T., V. K. Kuchroo, and A. H. Sharpe. 2002. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease. Curr. Dir. Autoimmun 5:113.
28. Doyle, A. M., A. C. Mullen, A. V. Villarino, A. S. Hutchins, F. H. High, H. W. Lee, C. B. Thompson, and S. L. Reiner. 2001. Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells. J. Exp. Med. 194:893.
29. Kirman, J. K., S. McCoy, M. Hook, B. Pround, I. Delahunt, A. Orme, D. Frank, and G. Le Gros. 1999. CTLA-4 blockage enhances the immune response induced by Mycobacterium infection but does not lead to increased protection. Infect. Immun. 67:3786.
30. McCoy, K., M. Camberis, and G. Le Gros. 1997. Protective immunity to nematode infection is induced by CTLA-4 blockade. J. Exp. Med. 186:183.
31. Murphy, M. L., S. E. J. Cotterell, P. M. A. Gorak, C. R. Engwerda, and P. M. Kaye. 1998. Blockade of CTLA-4 enhances host resistance to the intracellular pathogen Leishmania donovani. J. Immunol. 161:4153.
32. Saha, B. S., S. Chattopadhyay, R. Germond, D. M. Harlan, and P. J. Perrin. 1998. CTLA-4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection. Eur. J. Immunol. 28:4213.
33. + T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockage of BT-1/CTLA-4 molecular pathway. J. Infect. Dis. 178:1847.
34. Green, L. C., K. R. Luzuriaga, D. A. Wagner, W. Rand, N. Istan, V. R. Young, and S. R. Tannenbaum. 1981. Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. USA 78:7764.
35. Schmid, I., C. H. Uittenbogaart, B. Keld, and J. Giorgi. 1994. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods 170:145.
36. + T lymphocytes induced by CTLA-4 crosslinking. Proc. Natl. Acad. Sci. USA 95: 10083.
37. + T cell death by apoptosis in experimental Chagas' disease. J. Immunol. 154:744.
38. Lopes, M. F., M. P. Nunes, A. Henriques-Pons, N. Giese, H. C. Morse III, W. F. Davidson, T. C. Araujo-Jorge, and G. A. DosReis. 1999. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Eur. J. Immunol. 1:8.
39. + T cells in HIV infection. Clin. Exp. Immunol. 115:451.
40. Leng, Q., Z. Bentwich, E. Magen, A. Kalinkovich, and G. Borkow. 2002. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS 16:519.
41. Jacobs, T., S. E. Graefe, S. Niknafs, I. Gaworski, and B. Fleischer. 2002. Murine malaria is exacerbated by CTLA-4 blockade. J. Immunol. 169:2323.
42. + T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J. Immunol. 170:2264.
43. Omer, F. M., J. B. de Souza, and E. M. Riley. 2003. Differential induction of TGF-β regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. J. Immunol. 171: 5430.
44. Gilliet, M., and Y. J. Liu. 2002. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195:695.
45. + T cells. J. Immunol. 168:2247.
46. McGuirck, P., and K. Mills. 2002. Pathogen-specific regulatory T cells provoke a shift in the Th1/2 paradigm in immunity to infectious diseases. Trends Immunol. 23:450.
47. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:253.
48. + regulatory T cells. Curr. Opin. Immunol. 13:644.
49. Gong, J. H., M. Zhang, R. L. Modlin, P. S. Linsley, D. Iyer, Y. Lin, and P. F. Barnes. 1996. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 64:913.
50. Silva, J. S., P. J. Morrissey, K. H. Grabstein, K. M. Mohler, D. Anderson, and S. G. Reed. 1992. Interleukin 10 and interferon γ regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169.
51. Cardillo, F., J. C. Voltarelli, S. G. Reed, and J. S. Silva. 1996. Regulation of Trypanosoma cruzi infection in mice by γ interferon and interleukin 10: role of NK cells. Infect. Immun. 64:128.
52. Gomes N. A., C. R. Gattass, V. Barreto-De-Souza, M. E. Wilson, and G. A. DosReis. 2000. TGF-β mediates CTLA-4 suppression of cellular immunity in murine kalaazar. J. Immunol. 164:2001.
53. + T cells. J. Exp. Med. 188:1849.
54. Silva, J. S., D. R. Twardzik, and S. G. Reed. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β). J. Exp. Med. 174:539.
55. Freire-de-Lima, C. G., D. O. Nascimento, M. B. Soares, P. T. Bozza, H. C. Castro-Faria-Neto, F. G. de Melo, G. A. DosReis, and M. F. Lopes. 2000. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403:199.
56. Sullivan, T. J., J. J. Letterio, A. van Elsas, M. Mamura, J. van Amelsfort, S. Sharpe, B. Metzler, B. C. A. Chambers, and J. P. Alison. 2001. Lack of a role for transforming factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl. Acad. Sci. USA 98:2587.
57. Federici, E. E., W. B. Abelmann, and F. A. Neva. 1964. Chronic and progressive myocarditis and myositis in C3H mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 13:272.
58. Bour-Jordan, H., J. L. Grogan, Q. Tang, J. A. Auger, R. M. Locksley, and J. A. Bluestone. 2003. CTLA-4 regulates the requirement for cytokine-induced signals in TH2 lineage commitment. Nat. Immunol. 4:182.